The National Gonorrhea Therapy Monitoring Study: II. Trends and seasonality of antibiotic resistance of Neisseria gonorrhoeae.
D000658:Amoxicillin / Q000494:pharmacology; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002440:Cefoxitin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D012621:Seasons; D000198:Spectinomycin / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology; D014481:United States
D000900:Anti-Bacterial Agents; D010406:Penicillins; D004917:Erythromycin; D002440:Cefoxitin; D000667:Ampicillin; D000658:Amoxicillin; D000198:Spectinomycin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole